Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities : true bioequivalence of a generic product of intravenous metronidazole
Some generic of vancomycin prescribed in the United States fail in vivo despite pharmaceutical equivalence (PE) and bioequivalence (BE) demonstrated by the FDA
Quality assessment of U. S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5)and 10(7)CFU injected into opposite thighs of neutropenic mice
In vivo pharmacodynamics of piperacillin/tazobactam : implications for antimicrobial efficacy and resistance suppression with innovator and generic products
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children
Active surveillance of the trachea or throat for MRSA is more sensitive than nasal surveillance and a better predictor of MRSA infections among patients in intensive care
